References
- Cohen S, Goldberg A. Muscle wasting in disease: molecular mechanisms and promising therapies. Drug Discovery. 2015;14:58–74.
- Tajbakhsh S. Skeletal muscle stem cells in developmental versus regenerative myogenesis. J Intern Med. 2009;266:372–389.
- Calegari F, Huttner WB. An inhibition of cyclin-dependent kinases that lengthens, but does not arrest, neuroepithelial cell cycle induces premature neurogenesis. J Cell Sci. 2003;116:4947–4955.
- Calegari F, Haubensak W, Haffner C, et al. Selective lengthening of the cell cycle in the neurogenic subpopulation of neural progenitor cells during mouse brain development. J Neurosci. 2005;25:6533–6538.
- Abukhdeir AM, Park BH. p21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med. 2008;10:e19.
- Ni QF, Zhang Y, Yu J, et al. miR‐92b promotes gastric cancer growth by activating the DAB2IP‐mediated PI3K/AKT signaling pathway. Cell Prolif. 2019;53:e12630.
- Wang C, Uemura M, Tomiyama E, et al. MicroRNA‐92b‐3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma. Cancer Sci. 2020;111:1146–1155.
- Sun Y, Feng Y, Zhang G, et al. The endonuclease APE1 processes miR-92b formation, thereby regulating expression of the tumor suppressor LDLR in cervical cancer cells. Ther Adv Med Oncol. 2019;11:1–20.
- Long M, Zhan M, Xu S, et al. miR-92b-3p acts as a tumor suppressor by targeting Gabra3 in pancreatic cancer. Mol Cancer. 2017;16:167.
- Wang K, Wang X, Zou J, et al. miR-92b controls glioma proliferation and invasion through regulating Wnt/beta-catenin signaling via Nemo-like kinase. Neuro Oncol. 2013;15:578–588.
- Chen Z, Li Z, Jiang C, et al. MiR‐92b‐3p promotes neurite growth and functional recovery via the PTEN/AKT pathway in acute spinal cord injury. J Cell Physiol. 2019;234:23043–23052.
- Yuva-Aydemir Y, Xu XL, Aydemir O, et al. Downregulation of the host gene jigr1 by miR-92 Is essential for neuroblast self-renewal in drosophila. PLOS Genet. 2015;11(5):e1005264.
- Hu ZQ, Luo JF, Yu XJ, et al. Targeting myocyte-specific enhancer factor 2D contributes to the suppression of cardiac hypertrophic growth by miR-92b-3p in mice. Oncotarget. 2017;8:92079–92089.
- Li Y, Feng C, Gao M, et al. MicroRNA‐92b‐5p modulates melatonin‐mediated osteogenic differentiation of bone marrow mesenchymal stem cells by targeting ICAM‐1. J Cell Mol Med. 2019;23:6140–6153.
- Nowakowski T, Fotaki J, Pollock V, et al. MicroRNA-92b regulates the development of intermediate cortical progenitors in embryonic mouse brain. PNAS. 2013;110:7056–7061.
- Sengupta S, Nie J, Wagner RJ, et al. MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells. Stem Cells. 2009;27:1524–1528.
- Lang F, Böhmer C, Palmada M, et al. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol Rev. 2006;86:1151–1178.
- Kong X, Liu F, Gao J. MiR-155 promotes epithelial-mesenchymal transition in hepatocellular carcinoma cells through the activation of PI3K/SGK3/β-catenin signaling pathways. Oncotarget. 2016;7:66051–66060.
- Lee J, Heo J, Kang H. miR-92b-3p-TSC1 axis is critical for mTOR signaling-mediated vascular smooth muscle cell proliferation induced by hypoxia. Cell Death Differ. 2019;26(9):1782–1795.
- Zhuang LK, Yang YT, Ma X, et al. MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST. Cell Death Dis. 2016;7:e2203.
- Li YY, Zheng XH, Deng AP, et al. MiR-92b inhibited cells EMT by targeting Gabra3 and predicted prognosis of triple negative breast cancer patients. Eur Rev Med Pharmacol Sci. 2019;23:10433–10442.
- Zhao C, Zhao F, Feng H, et al. MicroRNA-92b inhibits epithelial-mesenchymal transition-induced migration and invasion by targeting Smad3 in nasopharyngeal cancer. Oncotarget. 2017;8:91603–91613.
- Cheng L, Huo B, Wang Y, et al. Downregulation of microRNA‐92b‐3p suppresses proliferation, migration, and invasion of gastric cancer SGC‐7901 cells by targeting Homeobox D10. J Cell Biochem. 2019;120:17405‐17412.
- Chen Z, Liang S, Zhao Y, et al. miR-92b regulates Mef2 levels through a negative-feedback circuit during Drosophila muscle development. Development. 2012;139:3543–3552.